本报讯（刘进毛旭建姚瑶）近日，江苏省卫生健康委员会公布2024年度医学科研立项项目名单，《基于CRISPR技术的新型HIV基因型耐药筛查方案的构建及其临床应用研究》获重点项目支持，该项目由市疾控中心病原生物检验科王凤鸣研究员主持。

Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March: To access the live webcasts of Editas Medicine’s presentations, please visit the ...

Call for Papers! Cas12-mediated Genome Editing in Plants . Ca. 01. Time Schedule . Submission deadline: Sunday, 30th November ...

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive ...

Study advances gene-editing capabilities for cancer and medical research through genetic manipulations using Cas12a enzyme ...

Conventional CRISPR nucleases, including Cas9 and Cas12a, exceed the packaging limits of a single AAV vector, necessitating ...

Methods: In this study, we developed a recombinase polymerase amplification (RPA) combined with CRISPR/Cas12a assay, specifically targeting the FAdV-4 Hexon gene. RPA and CRISPR/Cas12a reagents were ...

A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a ...

Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...

A study published in Nature Communications and conducted by researchers from the Institute of Physics of the Chinese Academy of Sciences revealed new ...

“‘DuTracer’为单细胞水平的谱系追踪设立了新标准。”论文通讯作者彭广敦表示，该技术通过巧妙结合两种基因编辑工具CRISPR-Cas9和Cas12a，显著提升了细胞谱系追踪的精度和深度，为解析胚胎发育、器官再生及疾病机制提供了全新工具。

生物学中，细胞谱系示踪类似于绘制细胞家族树，来追溯细胞从起源到分化的完整历程。近日，中国科学院广州生物医药与健康研究院彭广敦研究团队开发出新型单细胞谱系示踪技术（DuTracer）。这一技术通过巧妙结合CRISPR-Cas9和Cas12a两种基因编辑 ...